Caladrius Biosciences Receives Advanced Therapy Medicinal Product Classification for CLBS12, its CD34+ Cell Therapy for Critical Limb Ischemia

July 15, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search